Paclitaxel, Cisplatin and Methotrexate Combination Chemotherapy is Active in the Treatment of Refractory Urothelial Malignancies

This publication has 9 references indexed in Scilit:

• Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro
  British Journal of Cancer, 1994
• Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
  Journal of Cancer Research and Clinical Oncology, 1993
• Letters to the editor: Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer
  Annals of Oncology, 1993
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
  Journal of Clinical Oncology, 1992
• Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors
  Cancer, 1991
• Treatment of Advanced Transitional Cell Carcinoma of the Bladder With Continuous-Infusion Gallium Nitrate
  JNCI: Journal of the National Cancer Institute, 1991
• Sequences of taxol and cisplatin: a phase I and pharmacologic study.
  Journal of Clinical Oncology, 1991
• M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium
  Journal of Urology, 1988
• Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.
  Journal of Clinical Oncology, 1985